UniProt ID | UIF_HUMAN | |
---|---|---|
UniProt AC | Q96QD9 | |
Protein Name | UAP56-interacting factor | |
Gene Name | FYTTD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 318 | |
Subcellular Localization | Nucleus, nucleoplasm . Nucleus speckle . | |
Protein Description | Required for mRNA export from the nucleus to the cytoplasm. Acts as an adapter that uses the DDX39B/UAP56-NFX1 pathway to ensure efficient mRNA export and delivering to the nuclear pore. Associates with spliced and unspliced mRNAs simultaneously with ALYREF/THOC4.. | |
Protein Sequence | MNRFGTRLVGATATSSPPPKARSNENLDKIDMSLDDIIKLNRKEGKKQNFPRLNRRLLQQSGAQQFRMRVRWGIQQNSGFGKTSLNRRGRVMPGKRRPNGVITGLAARKTTGIRKGISPMNRPPLSDKNIEQYFPVLKRKANLLRQNEGQRKPVAVLKRPSQLSRKNNIPANFTRSGNKLNHQKDTRQATFLFRRGLKVQAQLNTEQLLDDVVAKRTRQWRTSTTNGGILTVSIDNPGAVQCPVTQKPRLTRTAVPSFLTKREQSDVKKVPKGVPLQFDINSVGKQTGMTLNERFGILKEQRATLTYNKGGSRFVTVG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNRFGTRL -------CCCCCCCC | 7.98 | 19413330 | |
6 | Phosphorylation | --MNRFGTRLVGATA --CCCCCCCCCCCCC | 20.37 | 30576142 | |
12 | Phosphorylation | GTRLVGATATSSPPP CCCCCCCCCCCCCCC | 25.25 | 30266825 | |
14 | Phosphorylation | RLVGATATSSPPPKA CCCCCCCCCCCCCCC | 25.94 | 30266825 | |
15 | Phosphorylation | LVGATATSSPPPKAR CCCCCCCCCCCCCCC | 38.08 | 29255136 | |
16 | Phosphorylation | VGATATSSPPPKARS CCCCCCCCCCCCCCC | 36.75 | 29255136 | |
20 | Ubiquitination | ATSSPPPKARSNENL CCCCCCCCCCCCCCH | 63.31 | - | |
23 | Phosphorylation | SPPPKARSNENLDKI CCCCCCCCCCCHHHH | 54.04 | 30266825 | |
33 | Phosphorylation | NLDKIDMSLDDIIKL CHHHHCCCHHHHHHH | 25.54 | 23403867 | |
39 | Ubiquitination | MSLDDIIKLNRKEGK CCHHHHHHHHHHCHH | 39.79 | - | |
61 | Phosphorylation | NRRLLQQSGAQQFRM HHHHHHHHCCHHHHH | 24.12 | 22115753 | |
118 (in isoform 4) | Phosphorylation | - | 27.11 | 25056879 | |
118 | Phosphorylation | TGIRKGISPMNRPPL CCCCCCCCCCCCCCC | 27.11 | 30266825 | |
126 | Phosphorylation | PMNRPPLSDKNIEQY CCCCCCCCCCCHHHH | 52.92 | 30266825 | |
138 | Ubiquitination | EQYFPVLKRKANLLR HHHHHHHHHHHHHHH | 52.68 | - | |
140 | Sumoylation | YFPVLKRKANLLRQN HHHHHHHHHHHHHHC | 39.79 | - | |
140 | Acetylation | YFPVLKRKANLLRQN HHHHHHHHHHHHHHC | 39.79 | 7677927 | |
140 | Sumoylation | YFPVLKRKANLLRQN HHHHHHHHHHHHHHC | 39.79 | 28112733 | |
152 | Acetylation | RQNEGQRKPVAVLKR HHCCCCCCCEEEECC | 35.64 | 7677937 | |
161 | Phosphorylation | VAVLKRPSQLSRKNN EEEECCHHHHHHCCC | 48.03 | 30266825 | |
166 | Ubiquitination | RPSQLSRKNNIPANF CHHHHHHCCCCCCCC | 51.47 | - | |
179 | Ubiquitination | NFTRSGNKLNHQKDT CCCCCCCCCCCCCCH | 54.94 | - | |
205 | Phosphorylation | KVQAQLNTEQLLDDV CEEEECCHHHHHHHH | 33.43 | - | |
215 | Ubiquitination | LLDDVVAKRTRQWRT HHHHHHHHHCCCCCC | 42.57 | - | |
235 | Acetylation | GILTVSIDNPGAVQC CEEEEEECCCCCEEC | 48.00 | 19413330 | |
253 | Phosphorylation | QKPRLTRTAVPSFLT CCCCCCCCCCCCHHH | 27.11 | 28555341 | |
257 | Phosphorylation | LTRTAVPSFLTKREQ CCCCCCCCHHHHHCH | 26.70 | 23898821 | |
260 | Phosphorylation | TAVPSFLTKREQSDV CCCCCHHHHHCHHCC | 26.50 | 23898821 | |
261 | Ubiquitination | AVPSFLTKREQSDVK CCCCHHHHHCHHCCC | 56.96 | 19413330 | |
261 | Acetylation | AVPSFLTKREQSDVK CCCCHHHHHCHHCCC | 56.96 | 19413330 | |
282 | Phosphorylation | PLQFDINSVGKQTGM CCEEEECCHHHHHCC | 32.36 | 21406692 | |
290 | Phosphorylation | VGKQTGMTLNERFGI HHHHHCCCHHHHHCC | 27.98 | - | |
299 | Ubiquitination | NERFGILKEQRATLT HHHHCCCHHCEEEEE | 50.29 | - | |
304 | Phosphorylation | ILKEQRATLTYNKGG CCHHCEEEEEEECCC | 23.09 | 24173317 | |
309 | Ubiquitination | RATLTYNKGGSRFVT EEEEEEECCCCEEEE | 54.99 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
205 | T | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UIF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UIF_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-15 AND SER-16, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-15 AND SER-16, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY. |